WO2010118218A1 - Sweetener composition comprising high solubility form of rebaudioside a and method of making - Google Patents
Sweetener composition comprising high solubility form of rebaudioside a and method of making Download PDFInfo
- Publication number
- WO2010118218A1 WO2010118218A1 PCT/US2010/030370 US2010030370W WO2010118218A1 WO 2010118218 A1 WO2010118218 A1 WO 2010118218A1 US 2010030370 W US2010030370 W US 2010030370W WO 2010118218 A1 WO2010118218 A1 WO 2010118218A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rebaudioside
- sweetener composition
- composition
- crystal form
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
Definitions
- a form of rebaudioside A useful as a sweetener may be produced by crystallizing rebaudioside A from a mixture of steviol glycosides that are dissolved in an alcohol/water mixture. When the crystallization takes place in a solution that is low in water content (e.g., under 50%), followed by filtration and drying, a crystal form of rebaudioside A is obtained having an X-ray diffraction pattern substantially as shown in FIG. 1. This form is designated herein as "Form 1" of rebaudioside A. This form has high solubility in water, but contains residual solvent that is difficult to remove.
- a second crystal form of rebaudioside A is obtained.
- This form is believed to be a hydrated crystal form of rebaudioside A containing 4 molecules of water per molecule of rebaudioside A.
- This form is characterized as being low in residual solvent and having a low solubility in water.
- An X-ray diffraction pattern of this form is shown in FIG. 2.
- Form 2 of rebaudioside A typically has a fairly low solubility when dissolved in water. For example, the solubility of the Form 2 at 24 0 C is typically about 1 gram rebaudioside A/ 100 grams water or less.
- Form 1 and Form 2 will be designated herein as "standard crystal forms" of rebaudioside A.
- a sweetener composition of rebaudioside A that has a higher solubility in water than Form 2. While it is possible to produce solutions with high solubility using Form 1 , a solution produced from Form 1 crystals containing more than about 1 g/100 g water tends to convert to Form 2 within hours to days, leaving about 1 g/100 g water in solution. Increased solubility in water allows more of the sweetener to be dissolved in a food product in order to provide the desired sweetness level. Increased solubility may be desirable in food products such as syrups and concentrates. [0004] In view of the foregoing what is desired is a highly pure form of rebaudioside A that has a high solubility in water, remains in solution for at least several days, and is low in residual solvent.
- the invention relates to sweetener compositions comprising rebaudioside A and to methods of making the sweetener compositions.
- the sweetener compositions of the invention comprise a highly soluble crystal form of rebaudioside A, for example, that displays a solubility at 24 0 C in water of about 25 (grams rebaudioside A/per 100 grams water) or greater.
- the rebaudioside A has a solubility at 24 0 C in water ranging from about 30 (grams rebaudioside A/100 grams water) or greater, for example, about 30 to about 45 (grams rebaudioside A/100 grams water).
- the highly soluble form of rebaudioside A is free or substantially free of any organic solvent.
- the high solubility of the sweetener composition of the invention allows it to be used in applications such as syrups and concentrates.
- the high solubility rebaudioside A component of the sweetener composition of the invention displays a powder X-ray diffraction pattern that is substantially similar to FIG. 6.
- the X-ray diffraction pattern may display two or more of the peaks that are characteristic of the rebaudioside A composition of FIG. 6. More typically, the X-ray diffraction pattern displays three or more, four or more, five or more, or all six of the peaks that are characteristic of the X-ray diffraction pattern of FIG. 6. Examples of characteristic peaks include those listed below.
- the invention in another aspect, relates to a method of making a rebaudioside A composition
- a method of making a rebaudioside A composition comprising the steps of: (a) providing a rebaudioside A composition in a standard crystal form (Form 1 or Form 2) or in amorphous form; and (b) converting at least a portion of the rebaudioside A composition into a high solubility crystal form (Form 3).
- the rebaudioside A composition comprises about 90 % wt. or greater rebaudioside A, or about 95% wt. or greater rebaudioside A.
- the process of converting the standard crystal form into the high solubility crystal form (Form 3) comprises a ripening process.
- Ripening typically comprises heating a rebaudioside A composition in the presence of water at a temperature and for a time period sufficient to convert at least a portion of the rebaudioside A composition into a lower hydrate (e.g., a trihydrate) of rebaudioside A.
- a lower hydrate e.g., a trihydrate
- a rebaudioside A composition may be treated at temperatures above about 90 0 C under pressure sufficient to prevent boiling. Typically, the temperature may range from about 9O 0 C to about 200 0 C at a pressure ranging from about 0.7 to about 15 bar. Heating time may vary, for example, from about 30 minutes to 24 hours.
- a high solubility crystal form may be crystallized from a solution of water by evaporative crystallization, for example, at a pressure ranging from about 0.3 bar at 7O 0 C to about 15 bar at 200 0 C.
- the high solubility crystal form may be crystallized from a dilute alcohol solvent (e.g., about 20% wt. alcohol or less). This would enable bringing a wet cake from crystallization in ethanol directly into a ripening process to produce Form 3.
- a dilute alcohol solvent e.g., about 20% wt. alcohol or less. This would enable bringing a wet cake from crystallization in ethanol directly into a ripening process to produce Form 3.
- the invention relates to food products that comprise a sweetener composition of the invention comprising a high solubility rebaudioside A composition.
- Representative examples of food products include beverages (e.g., soda), syrups (i.e., water-based solutions comprising a sweetener composition of the invention), and concentrates.
- FIG. 1 is a powder X-ray diffraction pattern of Form 1.
- FIG. 2 is a DSC pattern of Form 1.
- FIG. 3 is a powder XRD pattern of Form 1 after drying at 85°C for 17 days.
- FIG. 4 is a powder X-ray diffraction pattern of Form 2.
- FIG. 5 is a DSC pattern of Form 2.
- FIG. 6 is a powder X-ray diffraction pattern of Form 3.
- FIG. 7 is a DSC pattern of Form 3.
- FIG. 8 is a schematic diagram of a ripening process according to the invention. DETAILED DESCRIPTION
- the invention relates to sweetener compositions and to methods of making sweetener compositions.
- the sweetener compositions of the invention comprise a novel crystal form of the compound rebaudioside A.
- the novel crystal form of rebaudioside A is characterized by having a high solubility in water as compared to prior crystal forms of rebaudioside A.
- the novel crystal form of the invention contains no organic solvent.
- the high water solubility is desirable for certain sweetening applications including, for example, beverages (e.g., sodas), syrups, and concentrates.
- the rebaudioside A crystal form of the invention is characterized by the crystals having a high solubility in water.
- the solubility of the rebaudioside A has a solubility in water at 24 0 C of about 25 (grams rebaudioside A/100 grams water) or greater, for example, typically ranging from about 30 to about 45 (grams rebaudioside A/100 grams water) at 24°C. Solubility in water may be determined as described in Examples 1 -2 herein.
- the rebaudioside A crystal form of the invention is characterized in having a powder X-ray diffraction pattern that is substantially similar to the X- ray diffraction pattern shown in FIG. 6.
- substantially similar it is meant that the X-ray diffraction pattern of the rebaudioside A crystal form displays a pattern of peaks that is similar in peak position and intensity such that one of skill in the art of X-ray diffraction pattern interpretation would conclude that the compounds have the same composition and crystal structure.
- the crystalline structure of rebaudioside A (i.e., "high solubility crystal form") is characterized in displaying two or more characteristic X-ray diffraction peaks as identified in TABLE 1.
- the peaks in TABLE 1 are characteristic of the high solubility crystal form as compared to other crystal forms of rebaudioside A such as the standard crystal form.
- the X-ray diffraction pattern contains three or more of the characteristic peaks, for example, 4 or more, 5 or more, or all 6 of the characteristic peaks.
- TABLE 1 Characteristic X-ray Diffraction Peaks
- the characteristic peaks typically have a peak position that varies about +/- 0.2.
- the presence of a peak at 4.4 may be satisfied by the presence of a peak in the range of 4.2 to 4.6.
- An X-ray diffraction pattern of the rebaudioside A compositions of the invention may be obtained using techniques known in the art for the characterization of organic compounds using X-ray diffraction techniques.
- radiation sources include CuK and synchrotron radiation.
- a sample of the composition is typically ground into a fine powder using a using a mortar and pestle or other grinding apparatus. The fine powder is then packed into an aluminum sample holder with a zero background silicon plate.
- the high solubility crystal form of rebaudioside A of the invention can be prepared, for example, by first preparing rebaudioside A in a previously known crystal form having a lower solubility in water (e.g., Form 2), and then converting the rebaudioside A in Form 2 to the high solubility crystal form of the invention ("high solubility crystal form") by a ripening process.
- the starting material may comprise a standard solvated form (e.g., Form 1) which may be ripened to provide the high solubility crystal form of the invention.
- an amorphous form of rebaudioside A may be converted to the high solubility crystal form of the invention.
- rebaudioside A crystals in Form 1 may be prepared, for example, by crystallizing rebaudioside A from an alcohol/water solvent mixture (e.g., 85% ethanol / 15% water). The resulting rebaudioside A crystal of Form 1 and has an X-ray diffraction spectra similar to that shown in FIG. 1.
- the rebaudioside A starting material has a purity of rebaudioside A ranging from about 90% wt. or greater or about 95% wt. or greater. In some embodiments the purity ranges from about 95% wt. to about 99.9 % wt. rebaudioside A.
- compositions include, for example, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, stevioside, dulcoside, and steviolbioside.
- non-rebaudioside A components are present in an amount ranging from about 0.1 to about 5 % wt.
- rebaudioside A in Form 2 may also be used as a starting material for preparing the high solubility crystal form of the invention.
- This form may be obtained, for example, by dissolving Form 1 in water at room temperature and allowing it to recrystallize to yield Form 2.
- Form 2 is a much less soluble in water than Form 1.
- the rebaudioside A composition e.g., standard crystal form (Form 1 or Form 2) or amorphous form
- the rebaudioside A composition is converted into the high solubility crystal form using a ripening process.
- the ripening process is conducted by exposing the rebaudioside A composition to high temperatures in the presence of water.
- a slurry of rebaudioside A in the Form 1 or Form 2 can be prepared by mixing the crystals with water, and stirring the mixture to form a slurry.
- the concentration or rebaudioside A in the slurry ranges from about 20% to about 50 % weight.
- the ripening process is typically conducted at a temperature that ranges from about 7O 0 C to 100 0 C, although other temperatures may be useful.
- the ripening process is typically conducted for a period of time ranging from about 12 hours to about 24 hours, although other time periods may also be useful.
- the slurry of rebaudioside A is slowly stirred or mixed while being heated.
- the ripening process causes at least a portion of the rebaudioside A composition to be converted into the high solubility crystal form of the invention.
- rebaudioside A composition e.g., standard crystal form or amorphous form
- high solubility crystal form Form 3
- rebaudioside A in a standard crystal form or amorphous form may be treated at temperatures above about 90 0 C under pressure sufficient to prevent boiling.
- the temperature may range from about 9O 0 C to about 200 0 C at a pressure ranging from about 0.7 to about 15 bar, more preferably about 100 0 C (1 bar) to about 150 0 C (5 bar).
- Heating time may vary, for example, from about 30 minutes to 24 hours, more preferably about 1 hour to 3 hours.
- Form 3 may be crystallized directly from a solution of water or dilute alcohol (e.g., about 20% wt alcohol or less) by evaporative crystallization at a pressure ranging from about 0.3 bar at 7O 0 C to about 15 bar at 200 0 C, more preferably 100 0 C (1 bar) to 150 0 C (5 bar).
- the high solubility crystal form may be produced by ripening in a dilute alcohol (e.g., about 20% wt. alcohol or less). This would enable bringing a wet cake from crystallization in ethanol directly into a conversion process to produce Form 3.
- the resulting high solubility crystal form may be recovered by conventional filtration process, for example, using a B ⁇ chner funnel. In a production environment recovery may take place, for example, by centrifugation, pannevis filtration, nutch, rosenmund, and the like.
- the recovered product can be dried by exposure to a nitrogen stream and/or exposure to heat and/or vacuum (e.g., a vacuum oven).
- the conversion process (e.g., ripening process) converts Form 1, which is believed to be an ethanol solvate of rebaudioside A, or Form 2 which is believed to be a tetrahydrate (i.e., reb A-4H 2 O), into a high solubility crystal form, which is believed to be a lower hydrate (e.g., a trihydrate) of rebaudioside A.
- a lower hydrate refers to a rebaudioside A crystal fo ⁇ n that has less than four associated water molecules per molecule or rebaudioside A.
- lower hydrates examples include trihydrates (rebA-3F ⁇ 2 ⁇ ), dihydrates (rebA-2H 2 O), and monohydrates (rebA ⁇ 2 O).
- Non-stoichiometric hydrates are also possible.
- the conversion of the tetrahydrate or ethanol solvate to a lower hydrate results in an increase in the solubility of the rebaudioside A.
- the high solubility rebaudioside A of the invention has a solubility in water at 24 0 C of about 25 (grams rebaudioside A/100 grams water) or greater, for example, typically ranging from about 30 to about 45 (grams rebaudioside A/100 grams water) at 24 0 C.
- DSC Analysis Calorimetric measurements were performed with a Mettler Toledo DSC 822e. Samples of 4-6mg were weighted and sealed into 40 ⁇ L aluminum pans. DSC runs were conducted over a temperature range of 25°C to 300 0 C at a rate of 10°C/min.
- Rebaudioside A in Form 1 was prepared as follows.
- Rebaudioside A in Form 2 was prepared as follows.
- Drying The filtered sample was dried at a vacuum oven (-85 0 C) for 1-14 days.
- the water content of the dried sample is typically about 7.0%.
- Form 3 of Rebaudioside A was prepared as follows.
- Procedure 1 4.5 g of Rebaudioside A (Form 1) was added in 4mL of water were in a vial. The suspension was stirred with a magnetic stirrer bar for couple of minutes at -90 0 C and -1 g of Rebaudioside A was added to the solution to increase the concentration. After the addition of extra solid, the solution was almost solidified so 0.5 mL of water was also added to the system. The solution with final concentration of -1.0 g/mL was stirred continuously at -9O 0 C for 15-20 hours. The undissolved solid was filtered immediately through a Buchner funnel while the solution was still hot. The filtered portion, which was a gel-like compound was immediately placed into a vacuum oven at 8O 0 C and dried for 6-10 hours.
- Form 1 4.5 g of Rebaudioside A (Form 1) was added in 4mL of water were in a vial. The suspension was stirred with a magnetic stirrer bar for couple of minutes at -90 0 C and -1 g of Rebaudioside A was added
- Procedure 2 4.0-5.0 g of Rebaudioside A (Form 2) was added in 3 mL of water in a vial. The suspension was stirred with a magnetic stirrer bar for couple of minutes at -90 0 C and 0.5 ⁇ 1 g of Rebaudioside A was added to the solution to increase the concentration. After the addition of extra solid, the solution was almost solidified so 0.5 mL of water was also added to the system. The solution with final concentration of 1.0 -1.6 g/mL was stirred continuously at -9O 0 C for 15-20 hours. The undissolved solid was filtered immediately through a Buchner funnel while the solution was still hot. The filtered portion, which was a gel-like compound was immediately placed into a vacuum oven at 8O 0 C and dried for 6-10 hours.
- Form 2 4.0-5.0 g of Rebaudioside A (Form 2) was added in 3 mL of water in a vial. The suspension was stirred with a magnetic stirrer bar for couple of minutes at -90 0 C and 0.5
- Procedure 3 ⁇ 5.0 g of Rebaudioside A (Form 1 or Form 2) was added in 10 mL of water in a glass jar. The suspension was heated at 80 ⁇ 100°C while being stirred with a magnetic stirrer bar until the material was completely dissolved. The glass jar was opened such that water from the solution was allowed to evaporate while being stirred with a magnetic stirrer at the temperature of 90-95 0 C until the crystals were produced. The crystals were dried in a vacuum oven at 90-95 0 C for 24 hours.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Seasonings (AREA)
Abstract
Disclosed are sweetener compositions comprising rebaudioside A and methods of making the sweetener compositions. The sweetener compositions comprise a highly soluble crystal form of rebaudioside A that displays, in some embodiments, a solubility at 24°C in water of about 25 (grams rebaudioside A/per 100 grams water) or greater. The high solubility of the sweetener composition of the invention allows it to be used in applications such as syrups and concentrates.
Description
SWEETENER COMPOSITION COMPRISING HIGH SOLUBILITY FORM OF REBAUDIOSIDE A AND METHOD OF MAKING
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Application Serial Number No. 61/168,072, filed April 9, 2009, the disclosure of which is incorporated herein by reference.
BACKGROUND
[0002] A form of rebaudioside A useful as a sweetener may be produced by crystallizing rebaudioside A from a mixture of steviol glycosides that are dissolved in an alcohol/water mixture. When the crystallization takes place in a solution that is low in water content (e.g., under 50%), followed by filtration and drying, a crystal form of rebaudioside A is obtained having an X-ray diffraction pattern substantially as shown in FIG. 1. This form is designated herein as "Form 1" of rebaudioside A. This form has high solubility in water, but contains residual solvent that is difficult to remove. However, if the crystallization of rebaudioside A is performed in a pure water or a high water content solution, or if crystals of Form 1 are slurried in water at room temperature, a second crystal form of rebaudioside A is obtained. This form is believed to be a hydrated crystal form of rebaudioside A containing 4 molecules of water per molecule of rebaudioside A. This form is characterized as being low in residual solvent and having a low solubility in water. An X-ray diffraction pattern of this form is shown in FIG. 2. Form 2 of rebaudioside A typically has a fairly low solubility when dissolved in water. For example, the solubility of the Form 2 at 240C is typically about 1 gram rebaudioside A/ 100 grams water or less. Form 1 and Form 2 will be designated herein as "standard crystal forms" of rebaudioside A.
[0003] In some sweetening applications it is desirable to provide a sweetener composition of rebaudioside A that has a higher solubility in water than Form 2. While it is possible to produce solutions with high solubility using Form 1 , a solution produced from Form 1 crystals containing more than about 1 g/100 g water tends to convert to Form 2 within hours to days, leaving about 1 g/100 g water in solution. Increased solubility in water allows more of the sweetener to be dissolved in a food product in order to provide the desired sweetness level. Increased solubility may be desirable in food products such as syrups and concentrates.
[0004] In view of the foregoing what is desired is a highly pure form of rebaudioside A that has a high solubility in water, remains in solution for at least several days, and is low in residual solvent.
SUMMARY
[0005] The invention relates to sweetener compositions comprising rebaudioside A and to methods of making the sweetener compositions. The sweetener compositions of the invention comprise a highly soluble crystal form of rebaudioside A, for example, that displays a solubility at 240C in water of about 25 (grams rebaudioside A/per 100 grams water) or greater. Typically, for example, the rebaudioside A has a solubility at 240C in water ranging from about 30 (grams rebaudioside A/100 grams water) or greater, for example, about 30 to about 45 (grams rebaudioside A/100 grams water). In many embodiments, the highly soluble form of rebaudioside A is free or substantially free of any organic solvent. The high solubility of the sweetener composition of the invention allows it to be used in applications such as syrups and concentrates.
[0006] In some embodiments, the high solubility rebaudioside A component of the sweetener composition of the invention displays a powder X-ray diffraction pattern that is substantially similar to FIG. 6. For example, the X-ray diffraction pattern may display two or more of the peaks that are characteristic of the rebaudioside A composition of FIG. 6. More typically, the X-ray diffraction pattern displays three or more, four or more, five or more, or all six of the peaks that are characteristic of the X-ray diffraction pattern of FIG. 6. Examples of characteristic peaks include those listed below.
[0007] In another aspect, the invention relates to a method of making a rebaudioside A composition comprising the steps of: (a) providing a rebaudioside A composition in a standard crystal form (Form 1 or Form 2) or in amorphous form; and (b) converting at least a portion of the rebaudioside A composition into a high solubility crystal form (Form 3). Typically, the rebaudioside A composition comprises about 90 % wt. or greater rebaudioside A, or about 95% wt. or greater rebaudioside A.
[0008] In an exemplary process, the process of converting the standard crystal form into the high solubility crystal form (Form 3) comprises a ripening process. Ripening typically comprises heating a rebaudioside A composition in the presence of water at a temperature and for a time period sufficient to convert at least a portion of the rebaudioside A composition into a lower hydrate (e.g., a trihydrate) of rebaudioside A.
[0009] Other processes may also be used to convert a rebaudioside A composition into a high solubility crystal form (Form 3). For example, a rebaudioside A composition may be treated at temperatures above about 900C under pressure sufficient to prevent boiling. Typically, the temperature may range from about 9O0C to about 2000C at a pressure ranging from about 0.7 to about 15 bar. Heating time may vary, for example, from about 30 minutes to 24 hours. In another process, a high solubility crystal form may be crystallized from a solution of water by evaporative crystallization, for example, at a pressure ranging from about 0.3 bar at 7O0C to about 15 bar at 2000C. In yet another process, the high solubility crystal form may be crystallized from a dilute alcohol solvent (e.g., about 20% wt. alcohol or less). This would enable bringing a wet cake from crystallization in ethanol directly into a ripening process to produce Form 3.
[0010] In yet another aspect, the invention relates to food products that comprise a sweetener composition of the invention comprising a high solubility rebaudioside A composition. Representative examples of food products include beverages (e.g., soda), syrups (i.e., water-based solutions comprising a sweetener composition of the invention), and concentrates.
BRIEF DESCRIPTION OF THE FIGURES FIG. 1 is a powder X-ray diffraction pattern of Form 1. FIG. 2 is a DSC pattern of Form 1.
FIG. 3 is a powder XRD pattern of Form 1 after drying at 85°C for 17 days. FIG. 4 is a powder X-ray diffraction pattern of Form 2. FIG. 5 is a DSC pattern of Form 2. FIG. 6 is a powder X-ray diffraction pattern of Form 3. FIG. 7 is a DSC pattern of Form 3. FIG. 8 is a schematic diagram of a ripening process according to the invention.
DETAILED DESCRIPTION
[0011] In the following description, reference is made to specific embodiments in which the invention may be practiced. It is to be understood that other embodiments may be utilized as changes may be made without departing from the scope of the present invention.
[0012] The invention relates to sweetener compositions and to methods of making sweetener compositions. The sweetener compositions of the invention comprise a novel crystal form of the compound rebaudioside A. The novel crystal form of rebaudioside A is characterized by having a high solubility in water as compared to prior crystal forms of rebaudioside A. In many embodiments, the novel crystal form of the invention contains no organic solvent. The high water solubility is desirable for certain sweetening applications including, for example, beverages (e.g., sodas), syrups, and concentrates.
[0013] As noted above, the rebaudioside A crystal form of the invention is characterized by the crystals having a high solubility in water. For example, in many embodiments, the solubility of the rebaudioside A has a solubility in water at 240C of about 25 (grams rebaudioside A/100 grams water) or greater, for example, typically ranging from about 30 to about 45 (grams rebaudioside A/100 grams water) at 24°C. Solubility in water may be determined as described in Examples 1 -2 herein.
[0014] In many embodiments, the rebaudioside A crystal form of the invention is characterized in having a powder X-ray diffraction pattern that is substantially similar to the X- ray diffraction pattern shown in FIG. 6. By substantially similar it is meant that the X-ray diffraction pattern of the rebaudioside A crystal form displays a pattern of peaks that is similar in peak position and intensity such that one of skill in the art of X-ray diffraction pattern interpretation would conclude that the compounds have the same composition and crystal structure.
[0015] In many embodiments, the crystalline structure of rebaudioside A (i.e., "high solubility crystal form") is characterized in displaying two or more characteristic X-ray diffraction peaks as identified in TABLE 1. The peaks in TABLE 1 are characteristic of the high solubility crystal form as compared to other crystal forms of rebaudioside A such as the standard crystal form. In many embodiments, the X-ray diffraction pattern contains three or more of the characteristic peaks, for example, 4 or more, 5 or more, or all 6 of the characteristic peaks.
TABLE 1 : Characteristic X-ray Diffraction Peaks
[0016] As noted in TABLE 1, the characteristic peaks typically have a peak position that varies about +/- 0.2. For example, the presence of a peak at 4.4 may be satisfied by the presence of a peak in the range of 4.2 to 4.6.
[0017] An X-ray diffraction pattern of the rebaudioside A compositions of the invention may be obtained using techniques known in the art for the characterization of organic compounds using X-ray diffraction techniques. Examples of radiation sources include CuK and synchrotron radiation. To prepare an X-ray diffraction pattern, a sample of the composition is typically ground into a fine powder using a using a mortar and pestle or other grinding apparatus. The fine powder is then packed into an aluminum sample holder with a zero background silicon plate. The powder X-ray diffraction pattern of the composition can then be obtained, for example, using a Rigaku Miniflex diffractometer with CuK radiation (λ = 1.54 A). Typical conditions include scanning at a scan speed of about 0.2 to 0.3 (°C/minute).
[0018] The high solubility crystal form of rebaudioside A of the invention can be prepared, for example, by first preparing rebaudioside A in a previously known crystal form having a lower solubility in water (e.g., Form 2), and then converting the rebaudioside A in Form 2 to the high solubility crystal form of the invention ("high solubility crystal form") by a ripening process. In another embodiment, the starting material may comprise a standard solvated form (e.g., Form 1) which may be ripened to provide the high solubility crystal form of the invention. In yet another embodiment, an amorphous form of rebaudioside A may be converted to the high solubility crystal form of the invention.
[0019] As a starting material for the method of the invention, rebaudioside A crystals in Form 1 may be prepared, for example, by crystallizing rebaudioside A from an alcohol/water solvent mixture (e.g., 85% ethanol / 15% water). The resulting rebaudioside A crystal of Form 1 and has an X-ray diffraction spectra similar to that shown in FIG. 1. Typically, the rebaudioside A starting material has a purity of rebaudioside A ranging from about 90% wt. or greater or about 95% wt. or greater. In some embodiments the purity ranges from about 95% wt. to about 99.9 % wt. rebaudioside A. Other materials in the composition include, for example,
rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, stevioside, dulcoside, and steviolbioside. Typically, the non-rebaudioside A components are present in an amount ranging from about 0.1 to about 5 % wt.
[0020] As a starting material, rebaudioside A in Form 2 may also be used as a starting material for preparing the high solubility crystal form of the invention. This form may be obtained, for example, by dissolving Form 1 in water at room temperature and allowing it to recrystallize to yield Form 2. Form 2 is a much less soluble in water than Form 1.
[0021] Once prepared, the rebaudioside A composition (e.g., standard crystal form (Form 1 or Form 2) or amorphous form) is treated in order to convert at least a portion of the rebaudioside A into the high solubility crystal form of the invention. In some embodiments, the rebaudioside A composition is converted into the high solubility crystal form using a ripening process. The ripening process is conducted by exposing the rebaudioside A composition to high temperatures in the presence of water. For example, a slurry of rebaudioside A in the Form 1 or Form 2 can be prepared by mixing the crystals with water, and stirring the mixture to form a slurry. Typically the concentration or rebaudioside A in the slurry ranges from about 20% to about 50 % weight. The ripening process is typically conducted at a temperature that ranges from about 7O0C to 1000C, although other temperatures may be useful. The ripening process is typically conducted for a period of time ranging from about 12 hours to about 24 hours, although other time periods may also be useful. Typically, during the ripening process, the slurry of rebaudioside A is slowly stirred or mixed while being heated. The ripening process causes at least a portion of the rebaudioside A composition to be converted into the high solubility crystal form of the invention. A schematic diagram of an exemplary embodiment of a ripening process is shown in FIG. 8.
[0022] Other processes may also be used to convert the rebaudioside A composition (e.g., standard crystal form or amorphous form) into the high solubility crystal form (Form 3). For example, to reduce processing time, rebaudioside A in a standard crystal form or amorphous form may be treated at temperatures above about 900C under pressure sufficient to prevent boiling. For example, the temperature may range from about 9O0C to about 2000C at a pressure ranging from about 0.7 to about 15 bar, more preferably about 1000C (1 bar) to about 1500C (5 bar). Heating time may vary, for example, from about 30 minutes to 24 hours, more preferably about 1 hour to 3 hours. In another process, Form 3 may be crystallized directly from a solution of water or dilute alcohol (e.g., about 20% wt alcohol or less) by evaporative crystallization at a pressure ranging from about 0.3 bar at 7O0C to about 15 bar at 2000C, more preferably 1000C (1 bar) to 1500C (5 bar). In yet another process, the high solubility crystal form may be produced
by ripening in a dilute alcohol (e.g., about 20% wt. alcohol or less). This would enable bringing a wet cake from crystallization in ethanol directly into a conversion process to produce Form 3.
[0023] After converting, the resulting high solubility crystal form may be recovered by conventional filtration process, for example, using a Bύchner funnel. In a production environment recovery may take place, for example, by centrifugation, pannevis filtration, nutch, rosenmund, and the like. The recovered product can be dried by exposure to a nitrogen stream and/or exposure to heat and/or vacuum (e.g., a vacuum oven).
[0024] Although not wishing to be bound by theory, it is believed that the conversion process (e.g., ripening process) converts Form 1, which is believed to be an ethanol solvate of rebaudioside A, or Form 2 which is believed to be a tetrahydrate (i.e., reb A-4H2O), into a high solubility crystal form, which is believed to be a lower hydrate (e.g., a trihydrate) of rebaudioside A. As used herein the term "lower hydrate" refers to a rebaudioside A crystal foπn that has less than four associated water molecules per molecule or rebaudioside A. Examples of lower hydrates include trihydrates (rebA-3FΪ2θ), dihydrates (rebA-2H2O), and monohydrates (rebAΗ2O). Non-stoichiometric hydrates are also possible. The conversion of the tetrahydrate or ethanol solvate to a lower hydrate results in an increase in the solubility of the rebaudioside A. Typically, the high solubility rebaudioside A of the invention has a solubility in water at 240C of about 25 (grams rebaudioside A/100 grams water) or greater, for example, typically ranging from about 30 to about 45 (grams rebaudioside A/100 grams water) at 240C.
[0025] The invention will now be described with reference to the following non-limiting Examples.
EXAMPLES
[0026] DSC Analysis: Calorimetric measurements were performed with a Mettler Toledo DSC 822e. Samples of 4-6mg were weighted and sealed into 40 μL aluminum pans. DSC runs were conducted over a temperature range of 25°C to 3000C at a rate of 10°C/min.
[0027] X-ray Diffraction: Powder X-ray diffraction patterns were obtained using a Rigaku Miniflex diffractometer with CuK radiation (λ = 1.54 A) at a scan speed of 0.2 to 0.3 (°C/minute).
EXAMPLE 1 :
[0028] Determination of Aqueous Solubility (Room Temperature) of Oven Dried Solid Obtained From Ripening of Standard Form at High Temperature in Water
[0029] 10 mg of sample was mixed with 0.5 mL deionized water and stirred by a magnetic stirrer at room temperature. As the solid was completely dissolved, more solid was
added to the system with the increments of 10-40 mg until the solution became cloudy, which corresponded to the final concentration of 0.41 g/mL. The cloudy solution was filtered through a Millex-GV 0.22 urn filter into a pre-weighted aluminum pan and the known mass of clear filtered solution was placed into an oven at 850C. The solvent was completely evaporated and the residual solid was weighted to determine solubility. The results of the testing are shown below. TABLE 2
EXAMPLE 2:
[0030] Determination of Aqueous Solubility (Room Temperature) of Dry Solid Obtained From Ripening of Water-Form at High Temperature with Starting Concentration of 1.5 g/mL.
[0031] 16 mg of sample was mixed with 1 mL deionized water and was stirred by a magnetic stirrer at room temperature. As the solid was completely dissolved, more solid was added to the system with the increments of 10-40 mg until the solution became cloudy, which corresponded to the final concentration of 0.4 g/mL. The cloudy solution was filtered through a Millex-GV 0.22 um filter into a pre-weighted aluminum pan and the known mass of clear filtered solution was placed into an oven at 850C. The solvent was completely evaporated and the residual solid was weighted to determine solubility. The results of the testing are shown below. TABLE 3
TABLE 4
Solubility of Form 2 (starting material) For Comparison.
[0032] Rebaudioside A in Form 1 was prepared as follows.
[0033] Crystallization: 2.1 g of Rebaudioside A and 40 mL was added in ethanol/water (85:15%, v/v) mixture solvent and the suspension was heated (~ 65 0C) and stirred with a magnetic stirrer bar on a magnetic hot plate until the material was completely dissolved. The solution was cooled down to room temperature (-24 0C) to achieve supersaturation and, then, was aged for two days. As spontaneous crystallization did not occur, -0.025 g of Rebaudioside A was added to the solution. Crystals were observed inside the solution within an hour, which were then allowed to grow overnight and then filtered. The filtered sample was dried at ambient environment (~24 0C) for 1 day.
[0034] Drying: After drying at a vacuum oven (-85 0C) for 17 days, the XRD pattern of the sample changed, (FIG. 3) indicating the original material was solvate whose structure changed upon desolvating.
EXAMPLE 4: Preparation or Rebaudioside A in Form 2
[0035] Rebaudioside A in Form 2 was prepared as follows.
[0036] Crystallization: 4.0 - 20.0 g of Rebaudioside A and 40 mL was added in water and the suspension was heated (60 - 80 0C) and stirred with a magnetic stirrer bar on a magnetic hot plate until the material was completely dissolved. The solution was cooled down to room temperature (-240C) to achieve supersaturation. Crystals were obtained within an hour or several days and, then, were filtered.
[0037] Drying: The filtered sample was dried at a vacuum oven (-850C) for 1-14 days. The water content of the dried sample is typically about 7.0%.
EXAMPLE 5: Preparation of Rebaudioside Form 3:
[0038] Form 3 of Rebaudioside A was prepared as follows.
[0039] Procedure 1 : 4.5 g of Rebaudioside A (Form 1) was added in 4mL of water were in a vial. The suspension was stirred with a magnetic stirrer bar for couple of minutes at -90 0C and -1 g of Rebaudioside A was added to the solution to increase the concentration. After the addition of extra solid, the solution was almost solidified so 0.5 mL of water was also added to the system. The solution with final concentration of -1.0 g/mL was stirred continuously at -9O0C for 15-20 hours. The undissolved solid was filtered immediately through a Buchner funnel while the solution was still hot. The filtered portion, which was a gel-like compound was immediately placed into a vacuum oven at 8O0C and dried for 6-10 hours.
[0040] Procedure 2: 4.0-5.0 g of Rebaudioside A (Form 2) was added in 3 mL of water in a vial. The suspension was stirred with a magnetic stirrer bar for couple of minutes at -90 0C and 0.5 ~1 g of Rebaudioside A was added to the solution to increase the concentration. After the addition of extra solid, the solution was almost solidified so 0.5 mL of water was also added to the system. The solution with final concentration of 1.0 -1.6 g/mL was stirred continuously at -9O0C for 15-20 hours. The undissolved solid was filtered immediately through a Buchner funnel while the solution was still hot. The filtered portion, which was a gel-like compound was immediately placed into a vacuum oven at 8O0C and dried for 6-10 hours.
[0041] Procedure 3 : ~ 5.0 g of Rebaudioside A (Form 1 or Form 2) was added in 10 mL of water in a glass jar. The suspension was heated at 80~100°C while being stirred with a magnetic stirrer bar until the material was completely dissolved. The glass jar was opened such that water from the solution was allowed to evaporate while being stirred with a magnetic stirrer at the temperature of 90-950C until the crystals were produced. The crystals were dried in a vacuum oven at 90-950C for 24 hours.
[0042] Drying: The water content of the dried sample was always -2.0% immediately after drying at a vacuum oven (-850C) for 14 days. However, the water content of the sample quickly increased with staying time out of a vacuum oven at room temperature (-240C)
[0043] Other embodiments of this invention will be apparent to those skilled in the art upon consideration of this specification or from practice of the invention disclosed herein. Various omissions, modifications, and changes to the principles and embodiments described herein may be made by one skilled in the art without departing from the true scope and spirit of the invention which is indicated by the following claims.
Claims
1. A sweetener composition comprising: a high solubility crystal form of rebaudioside A having a solubility in water at 24°C of about 25 (grams rebaudioside A/100 grams water) or greater.
2. The sweetener composition of claim 1 , wherein the high solubility rebaudioside A has a solubility in water at 240C of about 30 (grams rebaudioside A/ 100 grams water) or greater.
3. The sweetener composition of claim 1, wherein the high solubility rebaudioside A has a solubility in water at 240C of about 30 to about 45 (grams rebaudioside A/100 grams water).
4. The sweetener composition of claim 1 , wherein the high solubility rebaudioside A has a purity of about 95% wt. or greater.
5. The sweetener composition of claim 1, wherein the high solubility rebaudioside A has a crystal form with an X-ray diffraction pattern substantially as shown in FIG. 6.
6. The sweetener composition of claim 1 , wherein the high solubility rebaudioside A has a crystal structure that has an X-ray diffraction pattern containing two or more characteristic peaks selected from the following:
7. The sweetener composition of claim 6, wherein the X-ray pattern contains three or more of the characteristic peaks.
8. The sweetener composition of claim 6, wherein the X-ray pattern contains four or more of the characteristic peaks.
9. The sweetener composition of claim 6, wherein the X-ray pattern contains five or more of the characteristic peaks.
10. The sweetener composition of claim 6, wherein the X-ray pattern contains six characteristic peaks.
11. The sweetener composition of claim 1 , wherein the sweetener composition further comprises one or more of rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, stevioside, dulcoside, and steviolbioside.
12. The sweetener composition of claim 1, wherein the rebaudioside A is a lower hydrate.
13. The sweetener composition of claim 1 , wherein the rebaudioside A is a trihydrate.
14. A sweetener composition comprising: rebaudioside A having a crystal form having an X-ray diffraction pattern substantially as shown in FIG. 6.
15. The sweetener composition of claim 14, wherein the rebaudioside A is a lower hydrate.
16. The sweetener composition of claim 14, wherein the sweetener composition further comprises one or more of rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, stevioside, dulcoside, and steviolbioside.
17. A sweetener composition comprising: rebaudioside A crystal form that has an X-ray diffraction pattern containing two or more characteristic peaks selected from the following:
18. The sweetener composition of claim 17, wherein the X-ray pattern contains three or more of the characteristic peaks.
19. The sweetener composition of claim 17, wherein the X-ray pattern contains four or more of the characteristic peaks.
20. The sweetener composition of claim 17, wherein the X-ray pattern contains five or more of the characteristic peaks.
21. The sweetener composition of claim 17, wherein the X-ray pattern contains six characteristic peaks.
22. The sweetener composition of claim 17, wherein the rebaudioside A is a lower hydrate.
23. The sweetener composition of claim 17, wherein the sweetener composition further comprises one or more of rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, stevioside, dulcoside, and steviolbioside.
24. A food composition comprising a sweetener composition according to any one of claims 1-23.
25. A syrup comprising a sweetener composition according to any one of claims 1-23.
26. A method of making a sweetener composition comprising rebaudioside A, the method comprising the steps of
(a) providing a rebaudioside A composition; and
(b) converting at least a portion of the rebaudioside A composition to a high solubility crystal form having a solubility in water at 240C of about 25 (grams rebaudioside A/100 grams water) or greater.
27. A method of making a sweetener composition comprising rebaudioside A, the method comprising the steps of:
(a) providing a rebaudioside A composition; and
(b) converting at least a portion of the rebaudioside A composition to a high solubility crystal form having an X-ray diffraction pattern substantially as shown in FIG. 6.
28. A method of making a sweetener composition comprising rebaudioside A, the method comprising the steps of:
(a) providing a rebaudioside A composition; and
(b) converting at least a portion of the rebaudioside A composition to a high solubility crystal form having two or more characteristic peaks selected from the following:
29. The method of any one of claims 26-28, wherein the rebaudioside A composition is in a standard crystal form or in an amorphous form.
30. The method of claim 29, wherein the standard crystal form is Form 1 or Form 2.
31. The method of any one of claims 26-28, wherein the step of converting at least a portion of the rebaudioside A composition to a high solubility crystal form comprises the step of: ripening the rebaudioside A composition of step (a) by heating in water at an elevated temperature for a period of time sufficient to convert at least a least a portion of the standard crystal form into a high solubility crystal form having a solubility in water at 24°C of about 25 (grams rebaudioside A/ 100 grams water) or greater.
32. The method of claim 31, wherein the heating step takes place at a temperature ranging from about 7O0C to about 1000C.
33. The method of claim 31, wherein the heating step takes place for a period of about 12 to about 24 hours.
34. The method of any one of claims 26-28, wherein the step of converting at least a portion of the rebaudioside A composition to a high solubility crystal form comprises the step of: heating the rebaudioside A composition to a temperature of about 9O0C or greater in the presence of water and under pressure sufficient to prevent boiling.
35. The method of claim 34, wherein the temperature ranges from about 9O0C to about 2000C and wherein the pressure ranges from about 0.7 bar to about 15 bar.
36. The method of claim 34, wherein the temperature and pressure range from about 1000C at about 1 bar to about 1500C at about 5 bar.
37. The method of any one of claims 26-28, wherein the step of converting at least a portion of the rebaudioside A composition to a high solubility crystal form comprises the step of: crystallizing a high solubility crystal form of rebaudioside A from water or dilute alcohol in water by evaporative crystallization.
38. The method of claim 37, wherein the dilute alcohol in water comprises about 20% wt. alcohol or less.
39. The method of claim 37, wherein the evaporative crystallization is conducted at a pressure ranging from about 0.3 to about 15 bar at a temperature ranging from about 7O0C to about 2000C.
40. The method of any one of claims 26-28, wherein the step of converting at least a portion of the rebaudioside A composition to a high solubility crystal form comprises the step of: crystallizing a high solubility crystal form from a dilute alcohol solvent.
41. The method of any one of claims 26-28, wherein the standard crystal form is a tetrahydrate and the high solubility crystal form is a lower hydrate.
42. A sweetener composition comprising rebaudioside A produced according to the method of any one of claims 26-28.
43. A syrup comprising rebaudioside A produced according to the method of any one of claims 26-28.
44. A food product comprising a sweetener composition prepared according to the method of any one of claims 26-28.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10762425.6A EP2416670A4 (en) | 2009-04-09 | 2010-04-08 | Sweetener composition comprising high solubility form of rebaudioside a and method of making |
US13/263,392 US20120058236A1 (en) | 2009-04-09 | 2010-04-08 | Sweetener composition comprising high solubility form of rebaudioside a and method of making |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16807209P | 2009-04-09 | 2009-04-09 | |
US61/168,072 | 2009-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010118218A1 true WO2010118218A1 (en) | 2010-10-14 |
Family
ID=42936573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/030370 WO2010118218A1 (en) | 2009-04-09 | 2010-04-08 | Sweetener composition comprising high solubility form of rebaudioside a and method of making |
Country Status (5)
Country | Link |
---|---|
US (1) | US20120058236A1 (en) |
EP (1) | EP2416670A4 (en) |
AR (1) | AR076269A1 (en) |
UY (1) | UY32557A (en) |
WO (1) | WO2010118218A1 (en) |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011094423A1 (en) | 2010-01-28 | 2011-08-04 | Cargill, Incorporated | Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form |
WO2012109506A1 (en) | 2011-02-10 | 2012-08-16 | Purecircle Usa | Highly soluble stevia sweetener |
WO2013036366A1 (en) | 2011-09-07 | 2013-03-14 | Purecircle Usa Inc. | Highly soluble stevia sweetener |
CN103739640A (en) * | 2014-01-30 | 2014-04-23 | 诸城市浩天药业有限公司 | Stevioside A glycoside crystal and preparation method and application thereof |
CN103739639A (en) * | 2014-01-30 | 2014-04-23 | 诸城市浩天药业有限公司 | Stevioside A glycoside crystal and preparation method and application thereof |
WO2014132217A1 (en) | 2013-02-28 | 2014-09-04 | L'oreal | Composition comprising rebaudioside a and a substituted cellulose |
WO2014132219A2 (en) | 2013-02-28 | 2014-09-04 | L'oreal | Compostion containing rebaudioside a and an oxyethylenated surfactant |
US8911971B2 (en) | 2011-02-17 | 2014-12-16 | Purecircle Usa Inc. | Glucosyl stevia composition |
US8981081B2 (en) | 2010-03-12 | 2015-03-17 | Purecircle Usa Inc. | High-purity steviol glycosides |
US8993269B2 (en) | 2011-02-17 | 2015-03-31 | Purecircle Usa Inc. | Glucosyl stevia composition |
US9029426B2 (en) | 2010-12-13 | 2015-05-12 | Purecircle Sdn Bhd | Highly soluble Rebaudioside D |
US9060537B2 (en) | 2012-03-26 | 2015-06-23 | Pepsico, Inc. | Method for enhancing rebaudioside D solubility in water |
US9107436B2 (en) | 2011-02-17 | 2015-08-18 | Purecircle Sdn Bhd | Glucosylated steviol glycoside as a flavor modifier |
US9243273B2 (en) | 2012-05-22 | 2016-01-26 | Purecircle Sdn Bhd | Method for making rebaudioside X |
CN105722533A (en) * | 2013-07-12 | 2016-06-29 | 可口可乐公司 | Compositions and methods for improving rebaudioside M solubility |
US9386797B2 (en) | 2011-02-17 | 2016-07-12 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US9392799B2 (en) | 2011-02-17 | 2016-07-19 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US9474296B2 (en) | 2011-02-17 | 2016-10-25 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US9510611B2 (en) | 2010-12-13 | 2016-12-06 | Purecircle Sdn Bhd | Stevia composition to improve sweetness and flavor profile |
WO2017120480A1 (en) | 2016-01-07 | 2017-07-13 | Purecircle Usa Inc. | Highly soluble steviol glycosides |
US9752174B2 (en) | 2013-05-28 | 2017-09-05 | Purecircle Sdn Bhd | High-purity steviol glycosides |
US9771434B2 (en) | 2011-06-23 | 2017-09-26 | Purecircle Sdn Bhd | Products from stevia rebaudiana |
WO2017161987A1 (en) * | 2016-03-24 | 2017-09-28 | 诸城市浩天药业有限公司 | Steviolbioside crystal form, and manufacturing method and application therefor |
US9877501B2 (en) | 2011-06-03 | 2018-01-30 | Purecircle Sdn Bhd | Stevia composition |
US9894922B2 (en) | 2011-05-18 | 2018-02-20 | Purecircle Sdn Bhd | Glucosyl rebaudioside C |
US10004245B2 (en) | 2009-11-12 | 2018-06-26 | Purecircle Sdn Bhd | Granulation of a stevia sweetener |
US10021899B2 (en) | 2011-05-31 | 2018-07-17 | Purecircle Sdn Bhd | Stevia composition |
US20190194240A1 (en) * | 2016-08-09 | 2019-06-27 | Dsm Ip Assets B.V. | Crystallization of steviol glycosides |
US10480019B2 (en) | 2011-08-10 | 2019-11-19 | Purecircle Sdn Bhd | Process for producing high-purity rubusoside |
US10531683B2 (en) | 2005-10-11 | 2020-01-14 | Purecircle Sdn Bhd | Process for manufacturing a sweetener and use thereof |
JP2020031640A (en) * | 2019-10-04 | 2020-03-05 | カーギル インコーポレイテッド | Glycoside mixture |
US10696706B2 (en) | 2010-03-12 | 2020-06-30 | Purecircle Usa Inc. | Methods of preparing steviol glycosides and uses of the same |
US10780170B2 (en) | 2013-06-07 | 2020-09-22 | Purecircle Sdn Bhd | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier |
US10952458B2 (en) | 2013-06-07 | 2021-03-23 | Purecircle Usa Inc | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier |
US11202461B2 (en) | 2014-09-02 | 2021-12-21 | Purecircle Sdn Bhd | Stevia extracts |
US11414448B2 (en) | 2010-11-19 | 2022-08-16 | Cargill, Incorporated | Method for the enrichment of rebaudioside b and/or rebaudioside d in stevia-derived glycoside compositions using adsorb-desorb chromatography with a macroporous neutral adsorbent resin |
US11647771B2 (en) | 2015-10-26 | 2023-05-16 | Purecircle Usa Inc. | Steviol glycoside compositions |
US11653686B2 (en) | 2015-12-15 | 2023-05-23 | Purecircle Usa Inc. | Steviol glycoside compositions |
US11690391B2 (en) | 2011-02-17 | 2023-07-04 | Purecircle Sdn Bhd | Glucosylated steviol glycoside as a flavor modifier |
US11871771B2 (en) | 2011-02-17 | 2024-01-16 | Purecircle Sdn Bhd | Glucosyl Stevia composition |
US12016357B2 (en) | 2015-05-20 | 2024-06-25 | Cargill, Incorporated | Glycoside compositions |
US12016355B2 (en) | 2011-02-10 | 2024-06-25 | Purecircle Sdn Bhd | Stevia composition |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2076516B1 (en) * | 2006-10-27 | 2013-12-11 | Signal Pharmaceuticals LLC | Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
CN102802441B (en) * | 2009-06-16 | 2014-07-30 | 伊比西(北京)植物药物技术有限公司 | Process For Rebaudioside D |
US20110111115A1 (en) * | 2009-11-06 | 2011-05-12 | Jingang Shi | Rebaudioside a polymorphs and methods to prepare them |
US9578895B2 (en) | 2010-08-23 | 2017-02-28 | Epc (Beijing) Natural Products Co., Ltd. | Rebaudioside A and stevioside compositions |
US9795156B2 (en) | 2011-03-17 | 2017-10-24 | E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd | Rebaudioside B and derivatives |
US20140171519A1 (en) * | 2012-12-19 | 2014-06-19 | Indra Prakash | Compositions and methods for improving rebaudioside x solubility |
US10264811B2 (en) | 2014-05-19 | 2019-04-23 | Epc Natural Products Co., Ltd. | Stevia sweetener with improved solubility |
US10357052B2 (en) | 2014-06-16 | 2019-07-23 | Sweet Green Fields USA LLC | Rebaudioside A and stevioside with improved solubilities |
US10485256B2 (en) | 2014-06-20 | 2019-11-26 | Sweet Green Fields International Co., Limited | Stevia sweetener with improved solubility with a cyclodextrin |
RU2733441C2 (en) * | 2016-03-01 | 2020-10-01 | Вм. Ригли Джр. Компани | Sweetener compositions with prolonged sweetening effect |
JP7391017B2 (en) | 2017-10-06 | 2023-12-04 | カーギル インコーポレイテッド | Steviol glycoside solubility enhancer |
US10912733B2 (en) | 2018-11-30 | 2021-02-09 | Amerilab Technologies, Inc. | Rapidly disintegrating effervescent tablets and methods of making the same |
EP3952667A1 (en) | 2019-04-06 | 2022-02-16 | Cargill, Incorporated | Sensory modifiers |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070292582A1 (en) * | 2006-06-19 | 2007-12-20 | The Coca-Cola Company | Rebaudioside A Composition and Method for Purifying Rebaudioside A |
US20090053378A1 (en) * | 2007-05-22 | 2009-02-26 | The Coca-Cola Company | Sweetener Compositions Having Enhanced Sweetness and Improved Temporal and/or Flavor Profiles |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1243835A (en) * | 1998-08-05 | 2000-02-09 | 黑龙江垦区海林甜菊糖有限责任公司 | Process for extracting rebandioside A |
JP4345961B2 (en) * | 2003-05-22 | 2009-10-14 | 東洋精糖株式会社 | Stevia sweetener composition |
CA2676220C (en) * | 2007-01-22 | 2016-04-05 | Cargill, Incorporated | Method of producing purified rebaudioside a compositions using solvent/antisolvent crystallization |
-
2010
- 2010-04-08 EP EP10762425.6A patent/EP2416670A4/en not_active Withdrawn
- 2010-04-08 WO PCT/US2010/030370 patent/WO2010118218A1/en active Application Filing
- 2010-04-08 US US13/263,392 patent/US20120058236A1/en not_active Abandoned
- 2010-04-09 AR ARP100101210A patent/AR076269A1/en unknown
- 2010-04-09 UY UY0001032557A patent/UY32557A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070292582A1 (en) * | 2006-06-19 | 2007-12-20 | The Coca-Cola Company | Rebaudioside A Composition and Method for Purifying Rebaudioside A |
US20090053378A1 (en) * | 2007-05-22 | 2009-02-26 | The Coca-Cola Company | Sweetener Compositions Having Enhanced Sweetness and Improved Temporal and/or Flavor Profiles |
Non-Patent Citations (2)
Title |
---|
PRAKASH ET AL.: "Development of rebiana, a natural, non-caloric sweetener.", FOOD AND CHEMICAL TOXICOLOGY, vol. 46, July 2008 (2008-07-01), pages S75 - S82, XP002503939 * |
See also references of EP2416670A4 * |
Cited By (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10531683B2 (en) | 2005-10-11 | 2020-01-14 | Purecircle Sdn Bhd | Process for manufacturing a sweetener and use thereof |
US10004245B2 (en) | 2009-11-12 | 2018-06-26 | Purecircle Sdn Bhd | Granulation of a stevia sweetener |
EP2528455A1 (en) * | 2010-01-28 | 2012-12-05 | Cargill, Incorporated | Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form |
WO2011094423A1 (en) | 2010-01-28 | 2011-08-04 | Cargill, Incorporated | Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form |
EP2528455A4 (en) * | 2010-01-28 | 2013-11-27 | Cargill Inc | Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form |
AU2011210818B2 (en) * | 2010-01-28 | 2014-10-30 | Cargill, Incorporated | Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form |
US10696706B2 (en) | 2010-03-12 | 2020-06-30 | Purecircle Usa Inc. | Methods of preparing steviol glycosides and uses of the same |
US11773125B2 (en) | 2010-03-12 | 2023-10-03 | Purecircle Usa Inc. | Methods of preparing steviol glycosides and uses of the same |
US12037356B2 (en) | 2010-03-12 | 2024-07-16 | Purecircle Usa Inc. | Methods of preparing steviol glycosides and uses of the same |
US11155570B2 (en) | 2010-03-12 | 2021-10-26 | Purecircle Usa Inc. | Methods of preparing steviol glycosides and uses of the same |
US8981081B2 (en) | 2010-03-12 | 2015-03-17 | Purecircle Usa Inc. | High-purity steviol glycosides |
US11414448B2 (en) | 2010-11-19 | 2022-08-16 | Cargill, Incorporated | Method for the enrichment of rebaudioside b and/or rebaudioside d in stevia-derived glycoside compositions using adsorb-desorb chromatography with a macroporous neutral adsorbent resin |
US9510611B2 (en) | 2010-12-13 | 2016-12-06 | Purecircle Sdn Bhd | Stevia composition to improve sweetness and flavor profile |
US11950611B2 (en) | 2010-12-13 | 2024-04-09 | Purecircle Sdn Bhd | Highly soluble Rebaudioside D |
US11291232B2 (en) | 2010-12-13 | 2022-04-05 | Purecircle Sdn Bhd | Highly soluble Rebaudioside D |
US9029426B2 (en) | 2010-12-13 | 2015-05-12 | Purecircle Sdn Bhd | Highly soluble Rebaudioside D |
US12016355B2 (en) | 2011-02-10 | 2024-06-25 | Purecircle Sdn Bhd | Stevia composition |
EP2672841A4 (en) * | 2011-02-10 | 2014-11-26 | Purecircle Usa Inc | Highly soluble stevia sweetener |
US11856974B2 (en) | 2011-02-10 | 2024-01-02 | Purecircle Sdn Bhd | Highly soluble stevia sweetener |
US10362797B2 (en) | 2011-02-10 | 2019-07-30 | Purecircle Sdn Bhd | Stevia composition |
EP3488844A1 (en) | 2011-02-10 | 2019-05-29 | PureCircle USA Inc. | A method for producing a stevia sweetener |
EP3799857A1 (en) | 2011-02-10 | 2021-04-07 | PureCircle USA Inc. | A method for producing a stevia sweetener |
EP2672841A1 (en) * | 2011-02-10 | 2013-12-18 | Purecircle Usa Inc. | Highly soluble stevia sweetener |
US11812771B2 (en) | 2011-02-10 | 2023-11-14 | Purecircle Sdn Bhd | Stevia composition |
US9427006B2 (en) | 2011-02-10 | 2016-08-30 | Purecircle Sdn Bhd | Highly soluble Stevia sweetener |
WO2012109506A1 (en) | 2011-02-10 | 2012-08-16 | Purecircle Usa | Highly soluble stevia sweetener |
US9474296B2 (en) | 2011-02-17 | 2016-10-25 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US10602762B2 (en) | 2011-02-17 | 2020-03-31 | Purecircle Sdn Bhd | Glucosylated steviol glycoside as a flavor modifier |
US9392799B2 (en) | 2011-02-17 | 2016-07-19 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US9386797B2 (en) | 2011-02-17 | 2016-07-12 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US11229228B2 (en) | 2011-02-17 | 2022-01-25 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US11957144B2 (en) | 2011-02-17 | 2024-04-16 | Purecircle Sdn Bhd | Glucosylated steviol glycoside as a flavor modifier |
US10743572B2 (en) | 2011-02-17 | 2020-08-18 | Purecircle Sdn Bhd | Glucosylated steviol glycoside as a flavor modifier |
US8911971B2 (en) | 2011-02-17 | 2014-12-16 | Purecircle Usa Inc. | Glucosyl stevia composition |
US9615599B2 (en) | 2011-02-17 | 2017-04-11 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US8993269B2 (en) | 2011-02-17 | 2015-03-31 | Purecircle Usa Inc. | Glucosyl stevia composition |
US11871771B2 (en) | 2011-02-17 | 2024-01-16 | Purecircle Sdn Bhd | Glucosyl Stevia composition |
US11844365B2 (en) | 2011-02-17 | 2023-12-19 | Purecircle Sdn Bhd | Glucosyl Stevia composition |
US11690391B2 (en) | 2011-02-17 | 2023-07-04 | Purecircle Sdn Bhd | Glucosylated steviol glycoside as a flavor modifier |
US9107436B2 (en) | 2011-02-17 | 2015-08-18 | Purecircle Sdn Bhd | Glucosylated steviol glycoside as a flavor modifier |
US11678685B2 (en) | 2011-02-17 | 2023-06-20 | Purecircle Sdn Bhd | Glucosyl stevia composition |
US9055761B2 (en) | 2011-02-17 | 2015-06-16 | Purecircle Usa Inc. | Glucosyl Stevia composition |
US9894922B2 (en) | 2011-05-18 | 2018-02-20 | Purecircle Sdn Bhd | Glucosyl rebaudioside C |
US11950610B2 (en) | 2011-05-18 | 2024-04-09 | Purecircle Sdn Bhd | Glucosyl Rebaudioside C |
US10021899B2 (en) | 2011-05-31 | 2018-07-17 | Purecircle Sdn Bhd | Stevia composition |
US11712055B2 (en) | 2011-05-31 | 2023-08-01 | Purecircle Sdn Bhd | Stevia composition |
US11825867B2 (en) | 2011-06-03 | 2023-11-28 | Purecircle Sdn Bhd | Stevia composition |
US20180146700A1 (en) * | 2011-06-03 | 2018-05-31 | Purecircle Sdn Bhd | Stevia composition |
US9877501B2 (en) | 2011-06-03 | 2018-01-30 | Purecircle Sdn Bhd | Stevia composition |
US11279773B2 (en) | 2011-06-23 | 2022-03-22 | Purecircle Sdn Bhd | Products from Stevia rabaudiana |
US9771434B2 (en) | 2011-06-23 | 2017-09-26 | Purecircle Sdn Bhd | Products from stevia rebaudiana |
US10480019B2 (en) | 2011-08-10 | 2019-11-19 | Purecircle Sdn Bhd | Process for producing high-purity rubusoside |
US11464246B2 (en) | 2011-09-07 | 2022-10-11 | Purecircle Sdn Bhd | Highly soluble Stevia sweetener |
WO2013036366A1 (en) | 2011-09-07 | 2013-03-14 | Purecircle Usa Inc. | Highly soluble stevia sweetener |
EP3811786A1 (en) * | 2011-09-07 | 2021-04-28 | PureCircle USA Inc. | Highly soluble stevia sweetener and method for producing thereof |
US11957149B2 (en) | 2011-09-07 | 2024-04-16 | Purecircle Sdn Bhd | Highly soluble stevia sweetener |
EP2753189A4 (en) * | 2011-09-07 | 2015-06-03 | Purecircle Usa Inc | Highly soluble stevia sweetener |
US9060537B2 (en) | 2012-03-26 | 2015-06-23 | Pepsico, Inc. | Method for enhancing rebaudioside D solubility in water |
US9243273B2 (en) | 2012-05-22 | 2016-01-26 | Purecircle Sdn Bhd | Method for making rebaudioside X |
US10485257B2 (en) | 2012-05-22 | 2019-11-26 | Purecircle Sdn Bhd | Method of making steviol glycosides |
US11542537B2 (en) | 2012-05-22 | 2023-01-03 | Purecircle Sdn Bhd | High-purity steviol glycosides |
WO2014132217A1 (en) | 2013-02-28 | 2014-09-04 | L'oreal | Composition comprising rebaudioside a and a substituted cellulose |
WO2014132219A2 (en) | 2013-02-28 | 2014-09-04 | L'oreal | Compostion containing rebaudioside a and an oxyethylenated surfactant |
US9752174B2 (en) | 2013-05-28 | 2017-09-05 | Purecircle Sdn Bhd | High-purity steviol glycosides |
US11312984B2 (en) | 2013-05-28 | 2022-04-26 | Purecircle Sdn Bhd | High-purity steviol glycosides |
US12011017B2 (en) | 2013-06-07 | 2024-06-18 | Purecircle Usa Inc. | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier |
US10952458B2 (en) | 2013-06-07 | 2021-03-23 | Purecircle Usa Inc | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier |
US10780170B2 (en) | 2013-06-07 | 2020-09-22 | Purecircle Sdn Bhd | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier |
CN105722533A (en) * | 2013-07-12 | 2016-06-29 | 可口可乐公司 | Compositions and methods for improving rebaudioside M solubility |
CN103739640A (en) * | 2014-01-30 | 2014-04-23 | 诸城市浩天药业有限公司 | Stevioside A glycoside crystal and preparation method and application thereof |
CN103739639A (en) * | 2014-01-30 | 2014-04-23 | 诸城市浩天药业有限公司 | Stevioside A glycoside crystal and preparation method and application thereof |
US11230567B2 (en) | 2014-09-02 | 2022-01-25 | Purecircle Usa Inc. | Stevia extracts enriched in rebaudioside D, E, N and/or O and process for the preparation thereof |
US11202461B2 (en) | 2014-09-02 | 2021-12-21 | Purecircle Sdn Bhd | Stevia extracts |
US11856972B2 (en) | 2014-09-02 | 2024-01-02 | Purecircle Sdn Bhd | Stevia extracts |
US12016357B2 (en) | 2015-05-20 | 2024-06-25 | Cargill, Incorporated | Glycoside compositions |
US11647771B2 (en) | 2015-10-26 | 2023-05-16 | Purecircle Usa Inc. | Steviol glycoside compositions |
US11653686B2 (en) | 2015-12-15 | 2023-05-23 | Purecircle Usa Inc. | Steviol glycoside compositions |
EP3399873A4 (en) * | 2016-01-07 | 2019-10-16 | PureCircle USA Inc. | Highly soluble steviol glycosides |
WO2017120480A1 (en) | 2016-01-07 | 2017-07-13 | Purecircle Usa Inc. | Highly soluble steviol glycosides |
WO2017161987A1 (en) * | 2016-03-24 | 2017-09-28 | 诸城市浩天药业有限公司 | Steviolbioside crystal form, and manufacturing method and application therefor |
US11878992B2 (en) * | 2016-08-09 | 2024-01-23 | Dsm Ip Assets B.V. | Crystallization of steviol glycosides |
US20190194240A1 (en) * | 2016-08-09 | 2019-06-27 | Dsm Ip Assets B.V. | Crystallization of steviol glycosides |
JP2020031640A (en) * | 2019-10-04 | 2020-03-05 | カーギル インコーポレイテッド | Glycoside mixture |
Also Published As
Publication number | Publication date |
---|---|
AR076269A1 (en) | 2011-06-01 |
UY32557A (en) | 2010-11-30 |
EP2416670A4 (en) | 2014-05-21 |
EP2416670A1 (en) | 2012-02-15 |
US20120058236A1 (en) | 2012-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010118218A1 (en) | Sweetener composition comprising high solubility form of rebaudioside a and method of making | |
US9090647B2 (en) | Crystalline forms of rebaudioside B | |
AU2007261243B2 (en) | Rebaudioside a composition and method for purifying rebaudioside A | |
CA2687841A1 (en) | Stevioside polymorphic and amorphous forms, methods for their formulation, and uses | |
MX2012008546A (en) | Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form. | |
WO2012109506A1 (en) | Highly soluble stevia sweetener | |
JP2022069548A (en) | Crystals of 6'-sialyl lactose sodium salt and method for producing the same | |
JP2020523377A (en) | Crystalline functional sweetener | |
TW552264B (en) | Macrolide crystallines, process for preparation thereof and pharmaceutical composition comprising same | |
WO2017092703A1 (en) | Method for preparing amorphous obeticholic acid | |
AU2012265238B2 (en) | Crystallization of epirubicin hydrochloride | |
CA3058886C (en) | Method for manufacturing diastereomer of citric acid derivative | |
WO2000052019A2 (en) | Crystallization products of neotame and methods for producing same | |
JP6918790B2 (en) | Crystals of 3'-sialyllactose sodium salt / n-hydrate and its production method | |
MX2010007850A (en) | Solid forms of ortataxel. | |
WO2020004358A1 (en) | HYDRATE CRYSTAL OF 3',3'-cGAMP | |
JPS5885900A (en) | Manufacture of lactitol-hydrate and crystalline lactitol | |
Shen et al. | Hydrothermal preparation and crystal habit of X-zeolite powder | |
JP2023011874A (en) | Cyclic-di-amp sodium salt crystal | |
CN116813679A (en) | Stevioside RN crystal form H1 and preparation method and application thereof | |
CN116903687A (en) | Stevioside RA1G crystal form H4 and preparation method and application thereof | |
JPH0659188B2 (en) | Appearance Crystalline low-calorie sweetener composition manufacturing method | |
JPH11335389A (en) | Preparation of crystallized maltulose monohydrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10762425 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010762425 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13263392 Country of ref document: US |